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The homeostasis of multicellular organisms requires
terminally differentiated cells to preserve their line-
age specificity. However, it is unclear whether mech-
anisms exist to actively protect cell identity in
response to environmental cues that confer func-
tional plasticity. Regulatory T (Treg) cells, specified
by the transcription factor Foxp3, are indispensable
for immune system homeostasis. Here, we report
that conserved noncoding sequence 2 (CNS2), a
CpG-rich Foxp3 intronic cis-element specifically de-
methylated in mature Tregs, helps maintain immune
homeostasis and limit autoimmune disease devel-
opment by protecting Treg identity in response to
signals that shape mature Treg functions and drive
their initial differentiation. In activated Tregs, CNS2
helps protect Foxp3 expression from destabilizing
cytokine conditions by sensing TCR/NFAT activa-
tion, which facilitates the interaction between CNS2
and Foxp3 promoter. Thus, epigenetically marked
cis-elements can protect cell identity by sensing
key environmental cues central to both cell identity
formation and functional plasticity without interfering
with initial cell differentiation.
INTRODUCTION
In multicellular organisms, terminally differentiated cells need to
preserve their lineage identity as well as exert a certain degree
of functional plasticity in response to different environment cues
to optimally function. Whether the environmental cues that confer
differentiated cells’ functional plasticity can also compromise
cell identity and whether mechanisms exist to actively guard
against potential loss of cell identity while preserving functional
plasticity is not clear. This is particularly relevant in the immune
system, where various immune cells have to cope with a wide
range of challenging conditions, including pathogen invasion of
hosts, inflammatory conditions, and host tissue damages. Im-
mune cellsmay be informedby these environmental cues through
an abundance of sensors to meet these challenges. Yet failure
to safeguard immune cell lineage identity can lead to either
compromised immune responses or autoimmune diseases.734 Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc.Regulatory T (Treg) cells are a distinct lineage of CD4+ T cells
that are essential for maintaining immune system homeostasis
by promoting self-tolerance and restraining excessive immune
responses (Sakaguchi et al., 2008). Foxp3, an X-chromosome-
encoded transcription factor belonging to the forkhead family,
plays an indispensable role in Treg lineage specification and
function (Josefowicz et al., 2012a). Expression of Foxp3 can
be induced in Treg precursors either in the thymus or in the pe-
riphery by a combination of TCR and cytokine signals. Mutation
of Foxp3 in mice results in severe lymphoproliferative disorder
and widespread tissue inflammation due to paucity of Treg cells
(Fontenot et al., 2003; Khattri et al., 2003). Additionally, ablation
or attenuation of Foxp3 expression in mature Treg cells leads to
dysregulation of Foxp3 target genes and compromised Treg
suppressor function (Wan and Flavell, 2007; Williams and Ru-
densky, 2007), indicating the requirement of constant Foxp3
expression for maintaining Treg lineage identity and function.
Fate-mapping studies have demonstrated that Foxp3 expres-
sion in Treg cells is remarkably stable in steady state and a num-
ber of inflammatory conditions, though moderate loss of Treg
Foxp3 expression owing to limited IL-2 availability has been
observed (Rubtsov et al., 2010). It is also possible that Foxp3
expression could be destabilized in Treg cells under other path-
ological conditions (Miyao et al., 2012; Rubtsov et al., 2010).
Despite the apparent stability of the Tregs, several lines of evi-
dence suggest that Tregs also possess a great degree of func-
tional plasticity (Sakaguchi et al., 2013). Expression of certain
polarizing transcription factors can endow Tregs with the ability
to specifically suppress effector CD4 T cells that express the
same polarizing transcription factor. For example, IRF4 expres-
sion in Tregs is essential for Tregs to control T helper type 2
(TH2) inflammation (Zheng et al., 2009). Expression of other tran-
scription factors such as T-bet, BLIMP1, GATA3, and STAT3 in
Tregs also affects specific aspects of Treg functions (Chaudhry
et al., 2009; Cretney et al., 2011; Koch et al., 2009; Wang
et al., 2011; Wohlfert et al., 2011). Tregs present in tissues
(tissular Tregs) have also been shown to have gene expression
programs distinct from Tregs in lymphoid organs, likely resulting
from residing in unique tissue environments that also confer
unique functions (Burzyn et al., 2013; Cipolletta et al., 2012).
Therefore, whether mechanisms exist to actively preserve the
identity of Tregs exhibiting these types of functional plasticity
is unclear.
Our previous investigation showed that, among three evolu-
tionarily conserved noncoding sequences (CNSs) located in
the Foxp3 intronic regions, CNS2 (also named TSDR for Treg-
specific demethylated region) plays a unique role in maintaining
Foxp3 expression in mature Treg cells (Zheng et al., 2010). In
comparison to other conserved cis-elements in the Foxp3 locus,
CNS2 is uniquely enriched with CpG motifs, which are specif-
ically demethylated during thymic Treg cell differentiation (Floess
et al., 2007). A number of transcription factors, including CREB,
NF-kB, Runx1, STAT5, Gata3, Foxo1, Ets1, and Foxp3 itself, can
interact with CNS2, though whether CNS2 plays a nonredundant
role for these transcription factors to regulate Foxp3 expression
is not clear (Bruno et al., 2009; Kim and Leonard, 2007; Kitoh
et al., 2009; Long et al., 2009; Ouyang et al., 2010; Ruan et al.,
2009; Rudra et al., 2009; Wang et al., 2011; Wohlfert et al.,
2011; Yao et al., 2007).
Here, we took advantage of the remarkable capability of Tregs
to maintain their identity while exhibiting a great degree of func-
tional plasticity to test whether an active mechanism exists to
prevent potential conflicts between these two properties. We
examined the physiological consequences of CNS2 deletion
and explored the mechanisms underlying CNS2-dependent
regulation of Foxp3 expression and Treg cell identity protection.
We found that the CNS2 knockout (CNS2–) mice developed
spontaneous lymphoproliferative disease and were more sus-
ceptible to experimental autoimmune encephalomyelitis (EAE),
though Treg cell numbers in most lymphoid organs were not
reduced in CNS2– mice. By performing unbiased gene expres-
sion profiling, we revealed that genes highly expressed in the
CNS2-dependent Treg subset fit the profiles of activated Treg
cells that receive strong TCR and cytokine stimulation, impli-
cating the role of CNS2 in protecting Treg identity in highly acti-
vated ‘‘effector’’ Tregs. Mechanistically, we found that CNS2
protected Treg identity from challenging cytokine conditions
that were known to impede initial Treg identity formation.
CNS2 helped to maintain mature Treg identity by sensing TCR
activation that is central for bothmature Treg functions and initial
Treg lineage specification, whereas CNS2 methylation before
Treg identity formation prevented undesired induction of Foxp3
expression. We identified NFAT as a CNS2-binding transcription
factor in response to TCR activation. Upon TCR stimulation,
CNS2 interacted with the Foxp3 promoter in an NFAT-depen-
dent manner to stabilize Foxp3 transcription in Treg cells. These
results demonstrated that a cis-element epigenetically switched
on during lineage differentiation can protect the identity of differ-
entiated cells in challenging environments by sensing signals
that are central to both lineage differentiation and mature cell
functional plasticity, without undesired perturbation of initial line-
age differentiation.
RESULTS
CNS2 Deletion Leads to Spontaneous
Lymphoproliferative Disease
We analyzed CNS2– (KO) and wild-type (WT) littermate control
mice to determine whether CNS2 is required for regulatory
T cells to control immune homeostasis in vivo. CNS2– mice ap-
peared to be normal up to 2 months of age when they started
to develop moderate lymphoproliferative disease with increased
cellularity in spleen and lymph nodes, correlated with lower bodyweight compared to littermates as they aged (Figures 1A, 1B,
and 1C). Histopathology analysis of 6- to 9-month-old CNS2–
mice revealed multifocal, moderate to severe perivascular and
peribronchiolar lympho-plasmacytic infiltration in the lung with
mild thickening of alveolar walls (Figure 1D). Lesions mostly con-
sisting of lympho-plasmacytic infiltration were also observed
frequently in liver and kidney of CNS2– mice, but not in littermate
control mice (Figure 1D). Furthermore, CNS2– mice also showed
evidence of lympho-plasmacytic enteritis in small intestines, with
multifocal infiltrations of the lamina propria with lymphocytes,
plasma cells, and neutrophils (Figure 1D). Thus, CNS2– mice
spontaneously develop lymphoproliferative disease manifesting
multiorgan inflammatory lesions.
Consistent with the role of Tregs in controlling T cell prolifera-
tion and activation (Josefowicz et al., 2012a), the numbers of
CD4+ T cells in the spleen and lymph nodes of CNS2– mice
increased compared to littermates (Figure 1E). Frequencies of
activated CD4+ T cells (CD44hi CD62Llo) also significantly in-
creased in the spleens, peripheral lymph nodes, mesenteric
lymph nodes, lamina propria of small and large intestines, and
lungs of CNS2– mice (Figure 1F and Figure S1A available online).
Moreover, frequencies of both IFN-g+ and IL-4+ CD4+ T cells
increased in the spleen and lymph nodes from CNS2– mice (Fig-
ure 1G), suggesting that both T helper type 1 (TH1) and T helper
type 2 (TH2) responses contributed to the pathology of CNS2
–
mice. IFN-g production by CD4+ T cells from Peyer’s patch
and lung and splenic CD8+ T cells also increased in CNS2–
mice (Figures S1B and S1C). In agreement with these results,
serum concentrations of IgE and IgG2c, which are associated
with TH2 and TH1 responses, respectively, were significantly
higher in CNS2– mice compared to WT littermates (Figure 1H).
Although frequency of IL-17A secreting T helper type 17 (TH17)
cells decreased in lymph nodes from CNS2– mice compared to
littermate controls, frequency of TH17 cells significantly
increased in Peyer’s patch and small intestines (Figure S1D).
These findings demonstrate that CNS2– mice have a general
defect in controlling excessive CD4+ T cell activation and prolif-
eration, as well as TH1, TH2, and TH17 cell differentiation.
CNS2-Dependent Tregs Are Enriched in the Foxp3lo
Subset of Tregs from CNS2– Mice
Because the main function of CNS2 is likely to regulate Foxp3
expression, we examined whether CNS2 deletion led to numer-
ical deficiency of Tregs or overall decrease of Foxp3 expression
in Tregs. CNS2– mice had a moderate decrease of Treg cell fre-
quency in spleen, but not in peripheral lymph nodes, mesenteric
lymph node, Peyer’s patch, lung, and lamina propria of small and
large intestines (Figures 2A and S2A). Interestingly, on a per cell
basis, Tregs in CNS2– and WT littermates had comparable over-
all Foxp3 expression levels (Figure S2B). Because a more lym-
phoproliferative environment in aged CNS2– mice might affect
Foxp3 expression, we analyzed Tregs in 6-week-old CNS2–
and CNS2wild-type Foxp3GFP (FG) mice. Frequency of Tregs in
spleen and lymph nodes of young CNS2– and Foxp3GFP mice
was comparable, whereas a small but significant decrease of
Foxp3 expression was observed in CNS2– Tregs (Figure 2B).
These results suggest that, at any given moment, CNS2 likely
regulates Foxp3 expression in a small subset of Tregs inCell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc. 735
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Figure 1. CNS2 Deletion in Mice Leads to Spontaneous Lymphoproliferative Disease
(A, B, D, H) Body weights (A), spleen weights (B), representative hematoxylin and eosin staining of small intestine, liver, kidney, and lung sections (D), and
concentration of IgE, IgG2c, IgG1, and IgA in serum, determined by enzyme-linked immunosorbent assay (H) of 6- to 9-month-old CNS2– (knockout, KO) and
littermate control (WT) mice. n = 5–7.
(C, E, F, and G) Cellularity (C), CD4+ and CD8+ T cell numbers (E), frequency of CD62Llo CD44hi cells in Foxp3– CD4+ T cells (F), and frequency of IFN-g+ and IL-4+
cells in CD4+ T cells (G) in spleens and peripheral lymph nodes (LN) from 9-month-old KO andWTmice. Numbers in upper-right quadrants (F, left) indicate percent
gated cells. n = 5–6.
All data are representative of three experiments. Mean ± SD. See also Figure S1.unprovoked mice, thus minimizing its effect on the overall Foxp3
expression level in the total Treg population.
We sought to use an unbiased approach to identify the subset
of Tregs that require CNS2 for stable Foxp3 expression. We hy-
pothesized that CNS2-dependent Tregs should express lower
levels of Foxp3 in CNS2– mice than in WT mice, resulting in their736 Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc.enrichment in the Foxp3lo population and depletion in the Fox-
p3hi population in CNS2–mice. To test this, we sorted Foxp3GFP
high, medium, and low populations from Foxp3GFP and CNS2–
mice and compared the stability of Foxp3 expression after
they were cultured for 3 days in vitro. Although all three subsets
of CNS2– Tregs lost more Foxp3 expression compared to the
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Figure 2. CNS2-Dependent Tregs Are Enriched in the Foxp3lo Treg Subset from CNS2– Mice
(A) Frequency of Foxp3+ cells in CD4+ T cells in spleen and peripheral lymph nodes (LN) from 9-month-old CNS2– (KO) and littermate control (WT) mice. n = 5–6.
(B) Flow cytometry analysis of Foxp3GFP expression in cells in spleen and LN from 6-week-old young CNS2– (KO) and CNS2wild-type Foxp3GFP (FG) mice. MFI,
mean fluorescence intensity. n = 4.
(C) Foxp3GFPlo (lo), Foxp3GFPmed (med), and Foxp3GFPhi (hi) Tregs from KO and FGmice (left) were cultured in vitro for 3 days before flow cytometry analysis of
Foxp3GFP expression (middle and right). Numbers in upper-left quadrants (middle) indicate percent Foxp3GFP– cells.
(D, E, and F) Equal numbers of Foxp3GFPlo (lo) and Foxp3GFPhi (hi) Tregs sort purified (E) from Ly5.1+ Ly5.2+ FG and Ly5.1– Ly5.2+ KO mice were mixed and
injected into Ly5.1+ Ly5.2– wild-type recipient mice intravenously. At 14 days later, transferred cells were analyzed by flow cytometry (F). n = 4.
All data are representative of three experiments. Mean ± SD. See also Figure S2.corresponding subsets of Foxp3GFP Tregs, the difference was
markedly higher in Foxp3lo Tregs than in Foxp3med and Foxp3hi
subsets (Figure 2C). To recapitulate this observation in vivo,
we cotransferred equal numbers of Foxp3hi (or Foxp3lo) Tregssorted from Ly5.1– Ly5.2+ CNS2– and Ly5.1+ Ly5.2+ Foxp3GFP
mice into Ly5.1+ Ly5.2– wild-type recipient mice and analyzed
transferred cells 14 days later (Figures 2D, 2E, and S2C). Again,
CNS2 deletion led to significantly greater loss of Foxp3Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc. 737
expression in the Foxp3lo subset than in the Foxp3hi subset of
Tregs (Figure 2F). Thus, the Foxp3lo subset of Tregs in CNS2–
mice are the most defective Treg subset in maintaining Foxp3
expression and are likely enriched with CNS2-dependent Tregs.
CNS2 Is Required for Activated ‘‘Effector’’ Tregs to
Maintain High Levels of Foxp3 Expression
To further characterize Tregs that depend on CNS2 to maintain
Foxp3 expression (enriched in the Foxp3lo Tregs in CNS2–
mice), we performed RNA-sequencing analysis to compare
gene expression profiles of Foxp3lo Tregs isolated from CNS2–
and Foxp3GFP mice. To minimize and control variations caused
by different inflammation levels between CNS2– and Foxp3GFP
mice, we used two individual 6- to 8-week-old mice for each ge-
notype and also profiled Foxp3hi Tregs as controls (Figure 3A).
Interestingly, clustering analysis indicated that the gene expres-
sion profile of CNS2– Foxp3lo Tregs was more similar to Foxp3hi
Tregs from both CNS2– and Foxp3GFP mice than to Foxp3lo
Tregs from Foxp3GFPmice (Figure 3B), consistent with the notion
that CNS2– Foxp3lo Tregs included some Tregs that would have
higher levels of Foxp3 expression were it not for CNS2
deficiency.
There were clusters of genes that were generally upregulated
or downregulated in CNS2– Tregs compared with Foxp3GFP
Tregs regardless of Foxp3 expression levels (Figure 3B and Ta-
ble S1), likely influenced by changes in environmental factors in
CNS2– mice, such as cytokine milieus, that could affect Treg
gene expression. To search for features of gene expression
more directly associated with CNS2 dependency, we identified
genes whose expression levels were higher in CNS2– Foxp3lo
Tregs than in Foxp3GFP Foxp3lo Tregs and/or lower in CNS2–
Foxp3hi Tregs than in Foxp3GFP Foxp3hi Tregs (Figure 3C). One
group of genes encode factors associated with cell growth and
division, including the cell proliferation marker Ki-67 (Mki67), cy-
clin and cyclin-dependent kinase (Ccnb2, Ccnb1, and Cdk1),
and others involved in T cell activation and proliferation
(Cdc25, Ttk, Cdkn2, Bub1, and Espl1) (Figure 3C). A second
group of genes encode chemokine receptors (Ccr2, Ccr5,
Ccr3, Cxcr6, Cxcr3, and Ccr4), cytokine receptors (Il23r, Il9r,
Il12rb1, and Il12rb2), and transcription factors playing key roles
in CD4+ T cell polarization (Rorc, Tbx21, and Prdm1) (Cretney
et al., 2011; Koch et al., 2009; Manel et al., 2008) (Figure 3C),
suggesting that CNS2-dependent Tregs were responsive to
chemotaxis and cytokine signals and differentiating into acti-
vated ‘‘effector’’ Tregs. The third group of genes were Treg
‘‘signature’’ genes, many of which are essential for Treg sup-
pressor function, including Il10, Ctla4, and Icos (Herman et al.,
2004; Rubtsov et al., 2008; Wing et al., 2008) (Figure 3C). Thus,
CNS2 is required for activated ‘‘effector’’ Tregs to maintain
higher levels of Foxp3 expression.
We next examined protein expression levels of several key
genes identified by gene expression profiling, including Ki-67,
CTLA4, and ICOS, in CNS2– and Foxp3GFP Tregs by flow cytom-
etry. The expression patterns of these genes in Foxp3lo and Fox-
p3hi Tregs in CNS2– and Foxp3GFP mice were in concordance
with the gene expression profiles generated by the RNA-seq
analysis (Figures 3D, 3E, and 3F). Consistent with key roles of
CTLA4 and ICOS in Treg function, the suppressor function of738 Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc.CNS2– Tregs was much lower compared to Foxp3GFP control
Tregs (Figure 3G). Interestingly, Foxp3hi Tregs had much higher
suppression capacity than Foxp3lo Tregs, and the small increase
in suppressor function of CNS2– Foxp3lo Tregs apparently could
not compensate for the decrease of suppressor function in
CNS2– Foxp3hi Tregs compared to their wild-type counterparts
(Figure S3A). In addition, at the end of the in vitro suppression
assay, more CNS2– Tregs lost Foxp3 expression compared to
Foxp3GFP Tregs irrespective of their original Foxp3 expression
levels (Figure S3B). Taken together, these results indicated that
CNS2 plays a critical role in maintaining high levels of Foxp3
expression and normal suppressor capacity in activated
‘‘effector’’ Tregs.
CNS2 Deletion Exacerbates Experimental Autoimmune
Encephalomyelitis Development
We hypothesized that the inability of CNS2– ‘‘effector’’ Tregs to
maintain Foxp3 expression could lead to exacerbation of auto-
immune diseases in CNS2– mice. To test this, we challenged
CNS2– mice with the experimental autoimmune encephalomy-
elitis (EAE) disease model. During EAE development, strong
TCR stimulation and abundant inflammatory cytokines, including
IL-6, lead to the activation, expansion, and differentiation of
CD4+ cells into TH1 and TH17 cells (Korn et al., 2009). CNS2
–
mice developed more severe disease and lost more body weight
compared to WT littermates during the course of the EAE (Fig-
ure 4A). This was accompanied with increased IFN-g-secreting
TH1 and IL-17A-secreting TH17 cells in the central nervous sys-
tem (CNS) of CNS2– mice (Figure 4B). Importantly, CNS2– mice
had severely reduced frequency of Tregs within CD4+ T cells in
the CNS (Figure 4C), whereas the reduction of Treg frequency
in the spleen was comparable to that observed in unchallenged
mice and much smaller than in the CNS (Figures 2A, 4C, and
S4A). In addition, Foxp3 expression in Tregs was also much
lower in CNS2– mice in the CNS, but not in the spleen (Figures
4D and S4B). These results indicate a critical role for CNS2 in
maintaining Tregs stability and numbers in an autoimmune dis-
ease setting.
CNS2 Helps Maintain Foxp3 Expression in Tregs in
Destabilizing Cytokine Environments
We next investigated the molecular mechanisms underlying the
requirement of CNS2 for ‘‘effector’’ Tregs to maintain Foxp3
expression. Given that CNS2-dependent Tregs were highly
capable of traveling to inflammation sites and being stimulated
by proinflammatory cytokines (Figure 3C), we examined whether
CNS2 helps to protect Treg identity in the presence of T-cell-
polarizing cytokines. Addition of IL-4 or IL-6, but not IL-12, to
cultured Foxp3GFPmed-hi Tregs greatly downregulated Foxp3
expression in CNS2–, but not Foxp3GFP Tregs (Figure 5A), indi-
cating that CNS2 is critical for Tregs to maintain Foxp3 ex-
pression in the presence of TH2- and TH17-related cytokines.
Addition of IL-4 and IL-6 to Treg cultures did not negatively affect
cell survival and proliferation (Figure S5A and data not shown). In
addition, reduction of Foxp3 expression in CNS2– Tregs treated
with IL-4 or IL-6 could still be observed when only proliferating
Foxp3GFP-positive Tregs were examined (Figures S5A and
S5B), suggesting that they have a direct inhibitory effect on
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Figure 3. CNS2 Is Required for ‘‘Effector’’ Tregs to Maintain High Levels of Foxp3 Expression
(A–C) Foxp3GFPlo (lo) and Foxp3GFPhi (hi) Tregs sort purified from 6-week-old CNS2– (KO) and Foxp3GFP (FG) mice (A) were used for RNA sequencing (RNA-seq)
analysis (B and C). n = 2. (B) Clustering of RNA-seq samples based on gene expression. (C) Genes enriched in the Foxp3lo subset and/or depleted in the Foxp3hi
subset of KO Tregs relative to FG Tregs, shown in groups based on their functions.
(D, E, and F) Ki67+ cell frequency (D) and expression of CTLA4 (E) and ICOS (F) in Foxp3lo and Foxp3hi Tregs from 2-month-old KO and FG mice. Numbers in
histograms indicate percent Ki67+ cell (D) and mean fluorescence intensity (MFI) of CTLA4 (E) and ICOS (F). n = 5–6.
(G) Suppression of proliferation of CellTrace Violet-labeled wild-type naive (CD62L+ CD44–) CD4+ T responder cells (Tresp) by KO and FG Tregs, presented as
dilution of CellTrace Violet in Tresp cells cultured with Tregs at indicated ratio (left).
Data are representative of two (A, B, C, and G) and three (D, E, and F) experiments. Mean ± SD. See also Figure S3 and Table S1.Tregs, not through negatively affecting cell health. The muted ef-
fect of IL-12 on CNS2– Tregs is possibly due to compromised
expression of IL-12Rb2 (Koch et al., 2012). As IL-2 neutralization
can mildly destabilize Foxp3 expression in mature WT Tregs
in vivo (Rubtsov et al., 2010), we askedwhether CNS2 is requiredfor maintaining Foxp3 expression in Tregs when IL-2 is limited.
Both Foxp3GFP and CNS2– Tregs cultured without exogenous
IL-2 had increased loss of Foxp3 expression (Figure 5A). Addi-
tion of a mouse IL-2 neutralizing antibody destabilized Foxp3
expression in CNS2– Tregs to a similar if not greater extentCell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc. 739
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Figure 4. CNS2 Deletion Exacerbates Experimental Autoimmune Encephalomyelitis Development in Mice
(A) Disease progression (left) and body weight (right) of CNS2– (KO) and littermate control mice (WT) after experimental autoimmune encephalomyelitis (EAE)
induction. n = 6–7.
(B, C, and D) Numbers of IL-17A+ and IFN-g+ CD4+ T cells (B), frequency of Foxp3+ CD4+ T cells (C), and mean fluorescence intensity (MFI) of Foxp3 in Foxp3+
CD4+ T cells (D) in CNS 22 days after EAE induction.
All data are representative of three experiments. Mean ± SD. See also Figure S4.than in wild-type FG Tregs (Figure 5B). Taken together, these
findings showed an important function for CNS2 to maintain
Foxp3 expression in Tregs exposed to cytokines IL-4 and IL-6
or when IL-2 is limited.
Foxp3 expression can be induced extrathymically in naive
CD4+ T cells to generate induced Tregs (iTregs) (Chen et al.,
2003). Whereas iTregs generated in vitro are not stable in the
absence of TGF-b (Floess et al., 2007), iTregs generated in vivo
can acquire stable Foxp3 expression and perform essential
functions (Josefowicz et al., 2012b; Polansky et al., 2008).
CNS2 deletion did not affect the induction and stability of in-vi-
tro-generated iTreg as expected (Figures S5C and S5D). To
examine whether CNS2 contributes to stable Foxp3 expression
in iTregs generated in vivo, we transferred Ly5.1– Ly5.2+
Foxp3GFP– naive CD4+ T cells from Foxp3GFP or CNS2– mice
together with cogenically marked Ly5.1+ Ly5.2– wild-type Tregs
into Rag1 knockout recipient mice (Figure 5C). At 12 days later,
Foxp3GFP and CNS2– iTregs (Ly5.1– Ly5.2+ Foxp3GFP+) were
isolated from recipient mice and activated in vitro to test Treg
stability (Figure 5C). Only 20% of CNS2– iTregs remained
Foxp3GFP positive compared to 60% of wild-type iTregs (Fig-
ure 5D). We also took advantage of Neuropilin 1 (Nrp1) as a
marker for natural Tregs (nTregs) to sort both nTregs (Nrp1+)
and iTregs (Nrp1–) from unprovoked Foxp3GFP and CNS2–
mice to test their lineage stability (Figure S5E) (Weiss et al.,
2012; Yadav et al., 2012). Again, CNS2 deletion significantly de-
stabilized Foxp3 expression in both nTregs and iTregs after
3 days of culture in vitro (Figure 5E). Taken together, these results
demonstrated an essential role of CNS2 in stabilizing Foxp3
expression in both nTregs and iTregs.740 Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc.CNS2 Is Required for Tregs Receiving Strong TCR
Stimulation to Maintain Elevated Foxp3 Expression
In Vitro and In Vivo
We next asked what signals promote stable Foxp3 expression
through CNS2. Given increased expression of proliferation-
associated genes in CNS2-dependent Tregs (Figure 3C),
increased loss of Foxp3 expression in divided cells (Zheng
et al., 2010), and the central role of TCR signaling in activation
and proliferation of Tregs (Walker et al., 2003), we evaluated
the effects of different TCR stimulation strengths on Foxp3
expression in CNS2– and Foxp3GFP Tregs. Increasingly stronger
TCR stimulation by anti-CD3 antibody progressively increased
and stabilized Foxp3 expression in Foxp3GFP Tregs. In contrast,
CNS2– Tregs failed to upregulate Foxp3, and more CNS2– Tregs
lost Foxp3 expression after receiving stronger TCR stimulation
(Figure 6A).
To examine how TCR stimulation regulates Foxp3 expres-
sion in wild-type and CNS2-deficient Tregs in vivo, we injected
superantigen staphylococcal enterotoxin B (SEB) or PBS into
CNS2– and Foxp3GFP mice and examined Foxp3 expression in
SEB-responsive TCR Vb8
+ and SEB-unresponsive TCR Vb6
+
Tregs 3 days later. SEB treatment increased Foxp3 expression
in Vb8
+ Tregs, but not in Vb6
+ Tregs in Foxp3GFP mice (Figures
6B and S6A). Importantly, SEB treatment failed to upregulate
Foxp3 expression in Vb8
+ Tregs in CNS2– mice (Figures 6B
and S6A).
To assess whether CNS2 helps to maintain stable Foxp3
expression in Tregs receiving strong TCR stimulation in vivo,
we also tested whether CNS2 deletion leads to preferential
loss of Foxp3 expression in proliferative Tregs rather than in
Foxp3GFP
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Figure 5. CNS2 Helps to Stabilize Foxp3 Expression in Tregs Exposed to Challenging Cytokine Conditions
(A and B) Foxp3GFP expression in CNS2– (KO) and Foxp3GFP (FG) Tregs cultured in the absence or presence of cytokines (IL-2, IL-12, IL-4, or IL-6) (A) or mouse
IL-2-neutralizing antibody (B) for 3 days. Numbers in histograms (A) indicate percent Foxp3GFP– cells.
(C and D) Foxp3GFP expression (D) in in-vivo-generated FG- and KO-induced Tregs (iTregs) (C) cultured in the presence of IL-2 for 3 days.
(E) Foxp3GFP expression in FG and KO natural Tregs (nTreg, Nrp1+) and iTregs (Nrp1–) cultured in the presence of IL-2 for 3 days.
All data are representative of at least two experiments. Mean ± SD. See also Figure S5.nonproliferative Tregs, as proliferative Tregs likely receive stron-
ger TCR stimulation than nonproliferative Tregs. We cotrans-
ferred equal numbers of Ly5.1– Ly5.2+ CNS2– and Ly5.1+
Ly5.2+ Foxp3GFPmed-hi Tregs stained with CellTrace Violet into
Ly5.1+ Ly5.2– wild-type mice and analyzed cell division and
Foxp3 expression in transferred cells 14 days after transfer (Fig-
ures S6B and 6C). CNS2– Tregs divided less compared with WT
Tregs (Figure S6C), in agreement with their decreased levels of
Ki-67 expression (Figure 3D). Importantly, CNS2 deletion led tosignificantly increased loss of Foxp3 expression and significantly
reduced Foxp3 expression in cells that remained Foxp3GFP+ in
highly divided, but not in nondivided, Tregs (Figure 6C). Thus,
both in vitro and in vivo, CNS2-dependent signal is important
for Tregs to upregulate and maintain Foxp3 expression levels
upon strong TCR stimulation.
Under chronic inflammatory conditions, a subset of Tregs can
lose Foxp3 expression and become ex-Tregs contributing to dis-
ease pathology (Bailey-Bucktrout et al., 2013; Komatsu et al.,Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc. 741
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Figure 6. CNS2 Is Required for Tregs Receiving Strong TCR Stimulation to Maintain Elevated Foxp3 Expression In Vitro and In Vivo
(A) Foxp3GFP expression in CellTrace Violet-labeled CNS2– (KO) and Foxp3GFP (FG) Tregs cultured in wells coated with 0.5, 1, 2, 5, or 10 mg/ml of anti-CD3 and
10 mg/ml of anti-CD28 for 3 days.
(legend continued on next page)
742 Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc.
2014). To examine whether CNS2– Tregs that had lost
Foxp3 expression could become cytokine-producing ex-Tregs
in vivo, we transferred CellTrace Violet-labeled Ly5.1– Ly5.2+
Foxp3GFPmed-hi Tregs from Foxp3GFP or CNS2– mice into con-
genically marked wild-type mice that had been immunized with
MOG/CFA 7 days before cell transfer and analyzed transferred
cells 7 days after transfer (Figure S6D). CNS2 deletion led to
increased loss of Foxp3 expression and reduced Foxp3 expres-
sion in Tregs that remained Foxp3 positive, especially in highly
divided cells (Figures 6D and S6E). Notably, most of the ex-Tregs
became IL-17A-secreting cells, and a higher percentage of
CNS2– Tregs became TH17 effector cells, probably because of
increased ex-Treg conversion (Figure 6D). It remains to be deter-
mined whether CNS2 deletion can also promote ex-Tregs to Th2
cell conversion in vivo.
Given that TCR also plays a central role in Treg lineage spec-
ification (Hsieh et al., 2006; Jordan et al., 2001; Moran et al.,
2011) and that CNS2 is only fully demethylated in mature Tregs
(Floess et al., 2007), we askedwhether enforcedCNS2 demethy-
lation in naive CD4 T cells activated in vitro can drive aberrant
Foxp3 induction (Figure 6E). Although it has been reported that
5-Aza could enhance Foxp3 induction (Lal et al., 2009; Polansky
et al., 2008), it is possible that 5-Aza promotes Foxp3 expression
through demethylation of other enhancer elements at the Foxp3
locus or through indirectly regulating other transcription factors
that modulate Foxp3 expression. As expected, 5-Aza increased
Foxp3 expression in naive CD4 T cells from Foxp3GFP mice (Fig-
ure 6E). Importantly, CNS2 was required for Foxp3 induction by
5-Aza (Figure 6E). Taken together, these results showed that
CNS2 senses TCR signals to increase and to maintain Foxp3
expression in mature Tregs and that its methylation prevents un-
desired Treg generation.
TCR Stimulation Activates NFAT to Facilitate the
Interaction between CNS2 and Foxp3 Promoter to
Stabilize Foxp3 Expression
We next asked what signals downstream of TCR are sensed
by CNS2 to promote and stabilize Foxp3 expression in Tregs.
Using retroviral expression of dominant-negative inhibitors, we
found that CREB and NF-kB can promote Foxp3 expression in
a CNS2-dependent manner in activated Tregs (Figures S7A
and S7B), in agreement with results from previous studies (Kim
andLeonard, 2007; Longet al., 2009;Ruan et al., 2009). These re-
sults suggested that other TCR-activated factors may contribute
to CNS2-dependent maintenance of Foxp3 expression.
We tested whether NFAT, one of the key players in TCR
signaling (Mu¨ller and Rao, 2010), can promote Foxp3 expression
through CNS2. NFAT has been shown to interact with the Foxp3
CNS1 region along with Smad3 to facilitate TGF-b-induced(B) Foxp3GFP expression in staphylococcal enterotoxin B (SEB)-responsive Vb8
mice 4 days after intravenous injection with 100 mg SEB or vehicle (PBS). n = 4.
(C) Foxp3 expression in cogenically marked CellTrace Violet-labeled KO and FG
(D) Foxp3 expression and IL-17A secretion in CellTrace Violet-labeled FG or KO Tr
7 days before cell transfer. n = 5.
(E) Foxp3GFP induction in KO and FG naive (Foxp3GFP– CD62Lhi CD44lo) CD4+
oxycytidine (Aza) (added 1 day after start of cell culture for the duration of 24 hr)
Mean ± SD. See also Figure S6.Foxp3 expression (Tone et al., 2008), but there was no report
linking NFAT to CNS2. Surprisingly, inhibition of the calci-
neurin-NFAT signaling pathway by cyclosporin A (CsA) signifi-
cantly reduced Foxp3 expression in activated wild-type Tregs,
but not in CNS2– Tregs (Figures 7A and S7C). Importantly,
CNS2 deletion did not further reduce Foxp3 expression in Tregs
treated with CsA (Figure 7A). Thus, NFAT plays a critical role in
CNS2-dependent regulation of Foxp3 expression.
Close examination of the CNS2 locus identified a potential
NFAT-binding site with high similarity to the consensus NFAT:
Foxp3-binding site (Wu et al., 2006) (Figures 7B and S7D). Both
NFATc1 and NFATc2 bound to DNA probes containing the puta-
tive CNS2 NFAT binding motif, but not to probes containing a
mutant NFAT motif in a DNA pull-down assay (Figure 7C). Dele-
tion of this site inCNS2greatly impaired the transactivation ability
of CNS2 in a luciferase reporter assay in both primary mouse
CD4+ T cells and Jurkat cells (Figures 7D and data not shown).
To determinewhetherNFAT binds toCNS2 in vivo,weperformed
chromatin immunoprecipitation (ChIP) assay. NFAT bound to
CNS2 in addition to Foxp3 promoter in WT Tregs, and its binding
to both locations was abolished by CsA (Figure 7E). Deletion of
CNS1 did not reduce NFAT binding to CNS2 (Figure S7E), and
both NFATc1 and NFATc2 could bind to CNS2 (Figure 7F).
Enhancer:promoter looping is one of the key mechanisms by
which enhancers regulate gene expression (Levine et al.,
2014). To examine whether CNS2 can physically interact with
Foxp3 promoter through a ‘‘looping’’ mechanism specifically
in Tregs, we performed chromatin conformation capture (3C)
assay (Dekker et al., 2002). We used a DpnII digestion fragment
encompassing the Foxp3 proximal promoter region as the
‘‘anchoring point’’ to assess the interaction frequency between
Foxp3 promoter and various regions across the Foxp3 locus
(Figure 7G). We placed the 3C qPCR primers for CNS2 at sites
next to CNS2 so that we could assess looping of the Foxp3 pro-
moter to the CNS2 proximal region if it occurs in the CNS2– Tregs
(Figure 7G). The Foxp3 promoter:CNS2 interaction was higher
than the interaction between Foxp3 promoter and other loca-
tions examined across the Foxp3 locus in Foxp3GFP Tregs (Fig-
ure 7G). Importantly, the Foxp3 promoter:CNS2 interaction
was6-fold higher in Tregs than in Foxp3GFP– CD4+ Tconv cells
(Figure 7G). In addition, in CNS2– Tregs, the interaction between
Foxp3 promoter and regions immediately adjacent to CNS2 was
reduced to the same basal level as in Tconv cells (Figure 7G). To
determine whether NFAT activity plays a role in the looping of
CNS2 to Foxp3 promoter, we performed 3C assaywithWT Tregs
that were untreated, activated with ionomycin, or activated with
ionomycin in the presence of CsA. The looping activity between
Foxp3 promoter and CNS2 was enhanced by ionomycin activa-
tion of NFAT, whereas the CsA blocked this looping activity+ and SEB-nonresponsive Vb6+ Tregs in spleens from 6-week-old KO and FG
Tregs 14 days after being cotransferred into wild-type mice. n = 5.
egs 7 days after being transferred intoWTmice immunized with MOG and CFA
T cells activated for 4 days in the absence or presence of 1 mM 5-Aza-20-de-
.
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(Figure 7H). Thus, NFAT promotes a specific interaction between
Foxp3 promoter and CNS2 in Tregs.
To evaluate a possible role of the looping interaction, we first
examined whether mediator and cohesin factors that were pre-
viously implicated in mediating interactions between promoters
and distal enhancers could bind to CNS2 and Foxp3 promoter
(Kagey et al., 2010). Both Med12 (a component of mediator)
and the cohesin loading factor Nipbl bound to both CNS2 and
Foxp3 promoter in activated Tregs, but not in conventional
T cells in ChIP assays (Figures 7I and 7K). Importantly, knock-
down of either of these two factors using shRNA vectors target-
ing previously validated target sequences (Kagey et al., 2010) led
to increased loss of Foxp3 expression in wild-type Foxp3GFP
Tregs, but not in CNS2– Tregs (Figures 7J and 7L), suggesting
that these factors contribute to CNS2-dependent maintenance
of Foxp3 expression in mature Tregs. Taken together, these
results suggest that CNS2 interacts specifically with Foxp3 pro-
moter in Tregs in an NFAT-dependent manner upon TCR activa-
tion to promote stable Foxp3 expression.
DISCUSSION
Terminally differentiated cells such as Tregs canmaintain lineage
stability while exerting certain degrees of functional plasticity in
response to external cues. It is unclear whether functional plas-
ticity could jeopardize cell lineage stability and whether mecha-
nisms are needed to resolve this potential conflict. Here, we
explored how Foxp3 CNS2, a CpG-rich cis-element accessible
only inmature regulatory T cells, protects Treg identity.We found
it somewhat surprising that, in unprovoked mice, CNS2 was
mainly required for highly activated ‘‘effector’’ Tregs to maintain
Foxp3 expression, but not for the majority of Tregs. These acti-
vated ‘‘effector’’ Tregs that particularly depended on CNS2 for
maintaining Foxp3 expression expressed increased levels of
genes that have been previously associated with Treg functional
plasticity, such as Tbx21 (encoding T-bet) and Prdm1 (encoding
BLIMP-1) (Cretney et al., 2011; Koch et al., 2009). This suggests
that Tregs that modulated their gene expression program and
functions in response to environmental cues (TCR activation, cy-Figure 7. TCR Stimulation Activates NFAT to Facilitate the Interaction
(A) Effects of NFAT inhibition with cyclosporin A (CsA) on Foxp3GFP expression
(10 mg/ml) and anti-CD28 (10 mg/ml) for 3 days.
(B) Alignment of a putative NFAT:Foxp3-binding site on mouse CNS2 (mCNS2) an
gene.
(C) Binding of NFATc1 and NFATc2 to the putative NFAT-binding element at CNS
served as positive and negative controls, respectively.
(D) Effects of deletion of the putative NFAT-binding site on the activity of CNS2 i
(E) NFAT binding to Foxp3 promoter and CNS2 analyzed by ChIP in wild-type Tre
Ctla4 and Gmpr genes served as positive and negative controls, respectively.
(F) NFATc1 and NFATc2 binding to CNS2 analyzed by ChIP in WT Tregs stimula
(G) Interaction of Foxp3 promoter with CNS2 and other locations within the Foxp3
KO mice measured by chromosome conformation capture (3C) assay after cells
(H) Interaction of CNS2 with Foxp3 promoter in wild-type Tregs measured by 3C
CsA for 30 min.
(I and K) Nipbl (I) or Med12 (K) binding to Foxp3 promoter, CNS2, and other locatio
with PMA and ionomycin.
(J and L) Foxp3GFP expression in FG and KO Tregs 3 days after cells were transdu
or Med12 (L).
All data are representative of at least two experiments. Mean ± SD. See also Figtokines, etc.) were more vulnerable to losing Treg identity in the
absence of CNS2 protection. It would be interesting to assess
whether any other environmental cues that have been shown
to shape Treg functional plasticity also require CNS2 to protect
Treg identity.
Our results also provided some tentative explanations of why
environmental cues that confer Treg functional plasticity also de-
stabilized CNS2-deficient Tregs. The conditions that promoted
loss of Foxp3 expression in CNS2-deficient Tregs bear a striking
similarity to those that have been shown by others to influence
Tregdevelopment in thymusandTregdifferentiation in theperiph-
ery. For example, the IL-2-signaling pathway has been shown to
be important for Treg differentiation (Chen et al., 2003; Fontenot
et al., 2005a). IL-4 and IL-6 have also been found by others to
inhibit Treg induction (Korn et al., 2008; Mantel et al., 2007). This
similarity likely results from methylated CNS2 in precursor cells
prior to Treg differentiation functionally mimicking a CNS2 dele-
tion. Inhibition of DNA methylation by 5-Aza has been shown to
promote Foxp3 induction even in the absence of TGF-b or in the
presenceofcytokines that could inhibit iTreggeneration.Although
CNS2 has been associated with the enhancement and stabiliza-
tion of Foxp3 expression by 5-Aza, the causal relationship be-
tween CNS2 demethylation and Foxp3 induction has not been
clearly established, and it is entirely possible that 5-Aza promotes
Foxp3 expression by removing DNAmethylation on other cis-ele-
ments at the Foxp3 locus or by regulating the expression levels of
other factors that can influence Foxp3 expression. We found that
CNS2was essential for 5-Aza tomediate theseeffects. Therefore,
whereasdemethylatedCNS2 inmatureTregsprotect cell identity,
methylated CNS2 may ensure that Treg differentiation can be
properly regulated by cytokine environments.
We found that CNS2 functions as a sensor to TCR signal to up-
regulate and maintain Foxp3 expression in activated Tregs.
Among numerous environmental cues that may shape mature
Treg functional plasticity, TCR activation might be a central
and shared signal in various conditions. TCR signaling also plays
a central role in Treg lineage specification (Hsieh et al., 2006; Jor-
dan et al., 2001; Moran et al., 2011). Thus, sensing TCR activa-
tion may provide a simple solution for Tregs to maintain Foxp3between CNS2 and Foxp3 Promoter to Promote Foxp3 Expression
in CNS2– (KO) and Foxp3GFP (FG) Tregs activated by plate-coated anti-CD3
d human CNS2 (hCNS2) with the consensus sites in human and mouseCTLA4
2. Wild-type and mutant IL-2 antigen receptor response elements (IL-2 ARRE)
n a luciferase reporter assay in mouse CD4+ T cells.
gs activated with ionomycin in the presence or absence of CsA for 30 min. The
ted with ionomycin.
locus in Tregs and Foxp3GFP– conventional CD4 T cells (Tconv) from FG and
were activated with ionomycin for 30 min.
assay after cells were activated with ionomycin in the presence or absence of
ns at the Foxp3 locus analyzed by ChIP inWT Tregs and Tconv cells stimulated
ced with control (Ctrl) RNAi retroviral vector and RNAi vector targeting Nipbl (J)
ure S7 and Tables S2, S3, and S4.
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expression. In addition to TCR signal, IL-2 is also a key player
involved in keeping stable Foxp3 expression in Tregs, possibly
through activation of STAT5 and its interaction with the Foxp3
promoter and CNS2 regions (Burchill et al., 2007; Yao et al.,
2007). The interplay between TCR and IL-2 signals in regulating
Foxp3 expression might be an adaptation to the complex envi-
ronment where Tregs survive and function.
In addition to transcription factors identified in previous
studies, we were able to establish a critical role for NFAT in
CNS2-dependent regulation of Foxp3 expression. We found
that NFAT binds to CNS2 both in vitro and in vivo, as well as to
Foxp3 promoter upon TCR stimulation. Using chromatin confor-
mation capture assay, we showed that CNS2 interacts with
Foxp3 promoter specifically in activated Tregs, but not in Tconv
cells in which CNS2 is methylated or in CNS2– Tregs, suggesting
that specific demethylation of CNS2 in mature Tregs may
contribute to the high specificity of the interaction between
Foxp3 promoter and CNS2 in these cells. The relative strength
of the interaction between Foxp3 promoter and CNS2 among
the examined interactions between Foxp3 promoter and other
locations spanning the Foxp3 locus also suggests an important
role for this particular interaction. Notably, we showed that
NFAT signaling is required for the interaction between Foxp3
promoter and CNS2. Although NFAT has been proposed to
participate in enhancer looping activity (Tsytsykova et al.,
2007), to the best of our knowledge, this is the first demonstra-
tion of experimental evidence supporting a key role of NFAT
signaling in the establishment of enhancer looping. Importantly,
the availability of CNS2-deficient Tregs allowed us to specifically
evaluate the function of an enhancer-promoter looping interac-
tion in the regulation of gene expression. We found that both
Med12 and Nipbl, two factors that have been shown to play
important roles in enhancer-promoter looping interactions,
bind to both CNS2 and Foxp3 promoter specifically in Tregs,
but not in Tconv cells. More importantly, knockdown of either
factor destabilized Foxp3 expression in wild-type Tregs, but
not in CNS2-deficient Tregs, suggesting that these looping fac-
tors help to stabilize Foxp3 expression in activated Tregs in a
CNS2-dependent manner.
In conclusion, we show how a cis-regulatory element could
play a crucial role in maintaining cell identity in response to
destabilizing environmental factors. Specifically, our studies
indicate that CNS2, which is demethylated during Treg develop-
ment, helps to maintain stable expression of Foxp3, the key Treg
lineage specification gene in destabilizing cytokine environ-
ments, by serving as a sensor to TCR activation, a key signal
among various external cues. Furthermore, we define a role for
NFAT in maintaining gene expression by facilitating enhancer-
promoter interaction. We suggest that these interactions provide
a framework for understanding how genetic and epigenetic pro-
grams establish dynamic processes in cell lineage determination
and maintenance.EXPERIMENTAL PROCEDURES
Mice
The generation of the CNS2– (Foxp3DCNS2) mice and Foxp3GFP mice has been
described (Fontenot et al., 2005b; Zheng et al., 2010). C57BL/6 and Ly5.1+ B6746 Cell 158, 734–748, August 14, 2014 ª2014 Elsevier Inc.congenic mice were purchased from the Jackson Laboratory. All mice were
maintained in the Salk Institute of Biological Studies SPF animal facility in
accordance with institutional regulations.
Histopathology
Mouse tissues were fixed in 10% phosphate-buffered formalin before being
processed for staining with hematoxylin and eosin according to standard
procedures.
Serum Immunoglobulin ELISA
Serum IgG2c, IgG1, and IgA concentrations were measured using SBA Clono-
typing System (Southern Biotech). IgE ELISAwas performed using biotinylated
anti-IgE detection antibody (BD Pharmingen) and streptavidin-conjugated
HRP.
RNA Sequencing
RNA was extracted with the TRIzol Reagent (Life Technologies). Multiplexed
libraries were constructed using the Illumina TruSeq RNA Sample Prep Kit.
Libraries were sequenced on the Illumina HiSeq 2000 according to the manu-
facturer’s instructions. The GEO accession number for RNA-seq data is
GSE57272.
In Vitro Suppression Assay
The division of responder T cells cocultured with irradiated antigen-pre-
senting cells and different amounts of Tregs was assessed by dilution of
CellTrace Violet, and the division index was calculated using FlowJo software
(TreeStar).
Adoptive Transfer of Tregs
Tregs were FACS sorted from total CD4+ T cells isolated from spleens and
lymph nodes of 6- to 8-week-old mice before being injected intravenously
into recipient mice.
DNA Pull-Down Assay
DNApull-down assaywas performed as previously described withminor mod-
ifications using biotinylated dsDNA probes listed in Table S4 (Zheng et al.,
2010).
Induction of EAE and Isolation of CNS Mononuclear Cells
EAE was induced and scored as previously described with modifications
(Stromnes and Goverman, 2006).
Luciferase Reporter Assay
CD62L+ CD44– CD4+ T cells were activated for 3 days before transfection with
luciferase reporter plasmids. Luciferase activities were measured at 24 hr after
transfection using Dual-Glo Luciferase Assay System (Promega).
In Vitro Treg Culture and Stability Assay
Tregs were activated for 72 hr with plate-coated anti-CD3 (145-2C11) and anti-
CD28 (37.51) or with Dynabeads Mouse T-activator CD3/CD28 (Life Technol-
ogies) before flow cytometry analysis of Foxp3 expression.
Retroviral and Lentiviral Infection
ACREB-expressing retroviral vector was previously described (Zheng et al.,
2010). IkBaM coding sequence was cloned into a Thy1.1-expressing retroviral
vector.
Chromatin Immunoprecipitation and qPCR
NFAT (Santa Cruz Biotechnology) ChIP was performed as previously
described (Zheng et al., 2009). Med12 and Nipbl ChIP was performed as
described previously (Kagey et al., 2010). qPCRs were performed using
primers listed in Table S2.
Chromatin Conformation Capture Assay and qPCR
Chromatin conformation capture assay was performed as previously
described with modifications (Spilianakis and Flavell, 2004). qPCRs were per-
formed using primers listed in Table S3.
Statistical Analysis
Statistical analyses were performed with Prism 6.0 (GraphPad). p values
were calculated using two-tailed unpaired Student’s t test or two-way analysis
of variance (ANOVA). p values of less than 0.05 were considered significant.
*p% 0.05, **p% 0.01, and ***p% 0.001 (Student’s t test).
ACCESSION NUMBERS
The GEO accession number for the RNA-seq data set reported in this paper is
GSE57272.
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Supplemental Information includes Extended Experimental Procedures, seven
figures, and four tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2014.07.030.
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